$AVAH
Aveanna Healthcare Holdings, Inc. Stock $avah

$avah Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-K Financial Statement

#000095017022004799 Filed on March 28, 2022

Income Statement

Concept	2022 Q1	2022
Revenue	$414.1M	$1.679B
YoY Change		12.27%
Cost Of Revenue	$289.7M	$1.136B
YoY Change		9.19%
Gross Profit	$124.4M	$542.4M
YoY Change		19.34%
Gross Profit Margin	30.04%	32.31%
Selling, General & Admin	$106.6M	$297.4M
YoY Change		23.42%
% of Gross Profit	85.72%	54.83%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$5.387M	$15.30M
YoY Change		17.69%
% of Gross Profit	4.33%	2.82%
Operating Expenses	$111.7M	$297.4M
YoY Change		23.42%
Operating Profit	$12.71M	-$36.11M
YoY Change		935.59%
Interest Expense	-$10.19M	$68.93M
YoY Change		-16.93%
% of Operating Profit	-80.2%
Other Income/Expense, Net	$1.127M	$4.914M
YoY Change		-85.74%
Pretax Income	-$122.1M	-$113.6M
YoY Change		119.54%
Income Tax	$4.080M	$3.468M
% Of Pretax Income
Net Earnings	-$126.2M	-$117.0M
YoY Change		105.16%
Net Earnings / Revenue	-30.48%	-6.97%
Basic Earnings Per Share		-$0.69
Diluted Earnings Per Share	-$682.6K	-$686.0K
COMMON SHARES
Basic Shares Outstanding	184.7M	170.6K
Diluted Shares Outstanding		170.6K

Balance Sheet

Concept	2022 Q1	2022	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$30.49M	$30.49M
YoY Change		-77.79%
Cash & Equivalents	$30.49M	$30.49M	$137.3M
Short-Term Investments
Other Short-Term Assets	$9.202M	$23.44M	$11.34M
YoY Change	-18.85%	4.62%
Inventory
Prepaid Expenses	$14.23M		$11.08M
Receivables	$218.9M	$225.3M	$172.9M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$279.2M	$279.2M	$340.6M
YoY Change	-18.03%	-18.02%
LONG-TERM ASSETS
Property, Plant & Equipment	$31.37M	$83.37M	$32.65M
YoY Change	-3.91%	5.66%
Goodwill	$1.836B		$1.316B
YoY Change	39.44%
Intangibles	$102.9M		$73.57M
YoY Change	39.8%
Long-Term Investments
YoY Change
Other Assets	$7.829M	$7.829M	$7.627M
YoY Change	2.65%	-26.14%
Total Long-Term Assets	$2.055B	$2.055B	$1.503B
YoY Change	36.7%	36.7%
TOTAL ASSETS
Total Short-Term Assets	$279.2M	$279.2M	$340.6M
Total Long-Term Assets	$2.055B	$2.055B	$1.503B
Total Assets	$2.334B	$2.334B	$1.844B
YoY Change	26.59%	26.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$52.62M	$52.62M
YoY Change		-7.19%
Accrued Expenses	$71.77M	$71.77M
YoY Change		0.94%
Deferred Revenue
YoY Change
Short-Term Debt	$7.451M	$7.451M
YoY Change		156.93%
Long-Term Debt Due	$8.600M	$129.2M	$9.910M
YoY Change	-13.22%	1130.48%
Total Short-Term Liabilities	$344.8M	$344.8M	$260.4M
YoY Change	32.42%	32.42%
LONG-TERM LIABILITIES
Long-Term Debt	$1.227B	$1.227B	$1.163B
YoY Change	5.42%	5.34%
Other Long-Term Liabilities	$16.69M	$121.3M	$30.96M
YoY Change	-46.08%	-2.16%
Total Long-Term Liabilities	$1.243B	$1.349B	$1.194B
YoY Change	4.08%	4.62%
TOTAL LIABILITIES
Total Short-Term Liabilities	$344.8M	$344.8M	$260.4M
Total Long-Term Liabilities	$1.243B	$1.349B	$1.194B
Total Liabilities	$1.696B	$1.696B	$1.577B
YoY Change	7.58%	7.59%
SHAREHOLDERS EQUITY
Retained Earnings	-$574.7M		-$457.6M
YoY Change	25.58%
Common Stock	$1.210B		$722.7M
YoY Change	67.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$635.8M	$638.0M	$265.0M
YoY Change
Total Liabilities & Shareholders Equity	$2.334B	$2.334B	$1.844B
YoY Change	26.59%	26.59%

Cashflow Statement

Concept	2022 Q1	2022
OPERATING ACTIVITIES
Net Income	-$126.2M	-$117.0M
YoY Change		105.16%
Depreciation, Depletion And Amortization	$5.387M	$15.30M
YoY Change		17.69%
Cash From Operating Activities	-$33.54M	-$11.35M
YoY Change		-109.73%
INVESTING ACTIVITIES
Capital Expenditures	-$5.644M	$15.95M
YoY Change		4.68%
Acquisitions		$666.9M
YoY Change		274.03%
Other Investing Activities	-$562.7M	-$665.9M
YoY Change		273.46%
Cash From Investing Activities	-$568.3M	-$681.8M
YoY Change		252.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$477.7M
YoY Change		855.38%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	510.6M	586.3M
YoY Change		177.95%
NET CHANGE
Cash From Operating Activities	-33.54M	-11.35M
Cash From Investing Activities	-568.3M	-681.8M
Cash From Financing Activities	510.6M	586.3M
Net Change In Cash	-91.22M	-106.9M
YoY Change		-179.73%
FREE CASH FLOW
Cash From Operating Activities	-$33.54M	-$11.35M
Capital Expenditures	-$5.644M	$15.95M
Free Cash Flow	-$27.89M	-$27.30M
YoY Change		-126.93%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2022Q1	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	0
CY2021Q1	us-gaap	Fair Value Assets Level1 To Level2 Transfers Amount FairValueAssetsLevel1ToLevel2TransfersAmount	0
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	0
CY2022Q1	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021Q1	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2021Q1	us-gaap	Preferred Stock Value PreferredStockValue
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue
CY2021Q1	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001832332
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--01-01
CY2021Q1	us-gaap	Fair Value Assets Level2 To Level1 Transfers Amount FairValueAssetsLevel2ToLevel1TransfersAmount	0
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent
CY2021Q1	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent
CY2021Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-01-01
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-40362
CY2022	dei	Entity Registrant Name EntityRegistrantName	Aveanna Healthcare Holdings Inc.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	81-4717209
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	400 Interstate North Parkway SE
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Atlanta
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	GA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	30339
CY2022	dei	City Area Code CityAreaCode	770
CY2022	dei	Local Phone Number LocalPhoneNumber	441-1580
CY2022	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
CY2022	dei	Trading Symbol TradingSymbol	AVAH
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	false
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2021Q3	dei	Entity Public Float EntityPublicFloat	526700000
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	184732268
CY2022	dei	Auditor Firm AuditorFirmId	42
CY2022	dei	Auditor Name AuditorName	Ernst & Young LLP
CY2022	dei	Auditor Location AuditorLocation	Atlanta, Georgia
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	30490000
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	137345000
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	218917000
CY2021Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	172887000
CY2022Q1	avah	Receivables Under Insured Programs Current ReceivablesUnderInsuredProgramsCurrent	6373000
CY2021Q1	avah	Receivables Under Insured Programs Current ReceivablesUnderInsuredProgramsCurrent	7992000
CY2022Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	14233000
CY2021Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	11080000
CY2022Q1	us-gaap	Other Assets Current OtherAssetsCurrent	9202000
CY2021Q1	us-gaap	Other Assets Current OtherAssetsCurrent	11340000
CY2022Q1	us-gaap	Assets Current AssetsCurrent	279215000
CY2021Q1	us-gaap	Assets Current AssetsCurrent	340644000
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	31374000
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	32650000
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	51992000
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	46217000
CY2022Q1	us-gaap	Goodwill Goodwill	1835580000
CY2021Q1	us-gaap	Goodwill Goodwill	1316385000
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	102851000
CY2021Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	73572000
CY2022Q1	avah	Receivables Under Insured Programs Noncurrent ReceivablesUnderInsuredProgramsNoncurrent	25530000
CY2021Q1	avah	Receivables Under Insured Programs Noncurrent ReceivablesUnderInsuredProgramsNoncurrent	23990000
CY2021Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2931000
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	7829000
CY2021Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	7627000
CY2022Q1	us-gaap	Assets Assets	2334371000
CY2021Q1	us-gaap	Assets Assets	1844016000
CY2022Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	52624000
CY2021Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	56668000
CY2022Q1	avah	Accrued Payroll And Employee Benefits AccruedPayrollAndEmployeeBenefits	54565000
CY2021Q1	avah	Accrued Payroll And Employee Benefits AccruedPayrollAndEmployeeBenefits	56834000
CY2022Q1	avah	Current Portion Of Insurance Reserves Insured Programs CurrentPortionOfInsuranceReservesInsuredPrograms	6373000
CY2021Q1	avah	Current Portion Of Insurance Reserves Insured Programs CurrentPortionOfInsuranceReservesInsuredPrograms	7992000
CY2022Q1	avah	Current Portion Of Insurance Reserves CurrentPortionOfInsuranceReserves	13466000
CY2021Q1	avah	Current Portion Of Insurance Reserves CurrentPortionOfInsuranceReserves	12294000
CY2022Q1	avah	Securitization Obligations SecuritizationObligations	120000000
CY2022Q1	us-gaap	Loans Payable Current LoansPayableCurrent	8600000
CY2021Q1	us-gaap	Loans Payable Current LoansPayableCurrent	9910000
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	13534000
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	11884000
CY2022Q1	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	25523000
CY2021Q1	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	24824000
CY2021Q1	avah	Government Stimulus Liabilities GovernmentStimulusLiabilities	29444000
CY2022Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	50146000
CY2021Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	50563000
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	344831000
CY2021Q1	us-gaap	Liabilities Current LiabilitiesCurrent	260413000
CY2022Q1	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	1226517000
CY2021Q1	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	1163490000
CY2022Q1	avah	Long Term Insurance Reserves Insured Programs LongTermInsuranceReservesInsuredPrograms	25530000
CY2021Q1	avah	Long Term Insurance Reserves Insured Programs LongTermInsuranceReservesInsuredPrograms	23990000
CY2022Q1	avah	Long Term Insurance Reserves LongTermInsuranceReserves	35122000
CY2021Q1	avah	Long Term Insurance Reserves LongTermInsuranceReserves	30336000
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	44682000
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	40246000
CY2021Q1	avah	Deferred Payroll Taxes DeferredPayrollTaxes	24824000
CY2022Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	3046000
CY2021Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	2591000
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	16692000
CY2021Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	30957000
CY2022Q1	us-gaap	Liabilities Liabilities	1696420000
CY2021Q1	us-gaap	Liabilities Liabilities	1576847000
CY2022Q1	avah	Deferred Restricted Stock Units DeferredRestrictedStockUnits	2135000
CY2021Q1	avah	Deferred Restricted Stock Units DeferredRestrictedStockUnits	2135000
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q1	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2021Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2021Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	184732268
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	184732268
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	141928184
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	141928184
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	1847000
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	1419000
CY2022Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1208645000
CY2021Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	721247000
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-574676000
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-457632000
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	635816000
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	265034000
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2334371000
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1844016000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1678618000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1495105000
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1384065000
CY2022	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	1136214000
CY2021	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	1040590000
CY2019	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	964814000
CY2022Q1	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	12200000
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	297381000
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	240946000
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	227762000
CY2022	avah	Corporate Expenses CorporateExpenses	130387000
CY2021	avah	Corporate Expenses CorporateExpenses	113828000
CY2019	avah	Corporate Expenses CorporateExpenses	113235000
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	117702000
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	75727000
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	20550000
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	17027000
CY2019	us-gaap	Depreciation And Amortization DepreciationAndAmortization	14317000
CY2022	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	12832000
CY2021	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	9564000
CY2019	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	22661000
CY2022	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	337000
CY2021	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-910000
CY2019	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-2322000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-36111000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-3487000
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	38954000
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	253000
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	345000
CY2019	us-gaap	Investment Income Interest InvestmentIncomeInterest	207000
CY2022	us-gaap	Interest Expense InterestExpense	68930000
CY2021	us-gaap	Interest Expense InterestExpense	82983000
CY2019	us-gaap	Interest Expense InterestExpense	92296000
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-13702000
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-73000
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-4858000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4914000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	34464000
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-17037000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-113576000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-51734000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-75030000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3468000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5316000
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1486000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-117044000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-57050000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-76516000
CY2022	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.69
CY2021	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.40
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.56
CY2022	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	170625000
CY2021	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	140972000
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	136906000
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	344993000
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1948000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-76516000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	270192000
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	50000000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1892000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-57050000
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	265034000
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	470108000
CY2022	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	3189000
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	970000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	13559000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-117044000
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	635816000
CY2022	us-gaap	Profit Loss ProfitLoss	-117044000
CY2021	us-gaap	Profit Loss ProfitLoss	-57050000
CY2019	us-gaap	Profit Loss ProfitLoss	-76516000
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	20550000
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	17027000
CY2019	us-gaap	Depreciation And Amortization DepreciationAndAmortization	14317000
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	8698000
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	7534000
CY2019	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	6724000
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	14839000
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	13197000
CY2019	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	12696000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	14425000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	3275000
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	1948000
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	117702000
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	75727000
CY2022	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-110000
CY2021	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-1843000
CY2019	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-1936000
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	14317000
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-4881000
CY2019	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-12151000
CY2019	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-1031000
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-13702000
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-73000
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-4858000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1313000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-6425000
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-919000
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	8808000
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-8563000
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3337000
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-6829000
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-3261000
CY2019	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-2088000
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-4475000
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	4280000
CY2019	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-4278000
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-11698000
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-6811000
CY2019	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	19292000
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-14026000
CY2021	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	11291000
CY2019	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	488000
CY2022	us-gaap	Increase Decrease In Self Insurance Reserve IncreaseDecreaseInSelfInsuranceReserve	2112000
CY2021	us-gaap	Increase Decrease In Self Insurance Reserve IncreaseDecreaseInSelfInsuranceReserve	4499000
CY2019	us-gaap	Increase Decrease In Self Insurance Reserve IncreaseDecreaseInSelfInsuranceReserve	8026000
CY2019	avah	Increase Decrease In Contingent Consideration IncreaseDecreaseInContingentConsideration	-4400000
CY2022	avah	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-15687000
CY2021	avah	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-13548000
CY2019	avah	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-13164000
CY2022	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	25876000
CY2021	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-46805000
CY2022	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	8649000
CY2021	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-6756000
CY2019	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	6885000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11350000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	116618000
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8714000
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	666915000
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	178307000
CY2019	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	957000
CY2019	avah	Payment For Disposal Of Business PaymentForDisposalOfBusiness	230000
CY2022	us-gaap	Payments For Derivative Instrument Investing Activities PaymentsForDerivativeInstrumentInvestingActivities	853000
CY2022	us-gaap	Proceeds From Derivative Instrument Investing Activities ProceedsFromDerivativeInstrumentInvestingActivities	1887000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	15950000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	15237000
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	16637000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-681831000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-193544000
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-17824000
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	477688000
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	50000000
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	970000
CY2022	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	2323000
CY2022	us-gaap	Proceeds From Accounts Receivable Securitization ProceedsFromAccountsReceivableSecuritization	150000000
CY2022	us-gaap	Repayments Of Accounts Receivable Securitization RepaymentsOfAccountsReceivableSecuritization	30000000
CY2021	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	14000000
CY2019	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	50000000
CY2021	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	45500000
CY2019	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	18500000
CY2022	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	1324531000
CY2021	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	180651000
CY2019	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	50000000
CY2022	avah	Repayment Of Term Loans RepaymentOfTermLoans	1273883000
CY2021	avah	Repayment Of Term Loans RepaymentOfTermLoans	8522000
CY2019	avah	Repayment Of Term Loans RepaymentOfTermLoans	8970000
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	8262000
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	3175000
CY2019	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	3595000
CY2019	avah	Proceeds From Issuance Of Bond Obligations ProceedsFromIssuanceOfBondObligations	560000000
CY2019	avah	Redemption Of Bond Obligations RedemptionOfBondObligations	560000000
CY2022	avah	Proceeds From Government Stimulus Funds ProceedsFromGovernmentStimulusFunds	2455000
CY2021	avah	Proceeds From Government Stimulus Funds ProceedsFromGovernmentStimulusFunds	29444000
CY2022	avah	Repayment Of Government Stimulus Funds RepaymentOfGovernmentStimulusFunds	31899000
CY2022	avah	Payments Of Financing Lease Obligations PaymentsOfFinancingLeaseObligations	795000
CY2021	avah	Payments Of Financing Lease Obligations PaymentsOfFinancingLeaseObligations	764000
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	5473000
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	2107000
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	15231000
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	3083000
CY2019	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1471000
CY2022	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	4192000
CY2022	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	1906000
CY2019	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	45600000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	586326000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	210944000
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	21864000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-106855000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	134018000
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4674000
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	137345000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3327000
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8001000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	30490000
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	137345000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3327000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	58959000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	73051000
CY2019	us-gaap	Interest Paid Net InterestPaidNet	92809000
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1637000
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1438000
CY2019	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	7301000
CY2019	avah	Acquisition Of Property And Equipment Under Financing Lease Obligations AcquisitionOfPropertyAndEquipmentUnderFinancingLeaseObligations	2806000
CY2021	avah	Offering Costs Included In Accounts Payable And Other Accrued Liabilities OfferingCostsIncludedInAccountsPayableAndOtherAccruedLiabilities	819000
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	5279000
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2171000
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1550000
CY2022	us-gaap	Nature Of Operations NatureOfOperations	<p id="footnotes_to_financial_statements" style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1. DESCRI</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">PTION OF BUSINESS</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Aveanna Healthcare Holdings Inc. (together with its consolidated subsidiaries, referred to herein as the “Company”) is headquartered in Atlanta, Georgia and has locations in</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> states </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">with concentrations in Texas, Pennsylvania, and California, providing a broad range of pediatric and adult healthcare services, including nursing, hospice, rehabilitation services, occupational nursing in schools, therapy services, day treatment centers for medically fragile and chronically ill children and adults, as well as delivery of enteral nutrition and other products to patients. The Company also provides case management services in order to assist families and patients by coordinating the provision of services between insurers or other payers, physicians, hospitals, and other healthcare providers. In addition, the Company provides respite healthcare services, which are temporary care provider services provided in relief of the patient’s normal caregiver. The Company’s services are designed to provide a high quality, lower cost alternative to prolonged hospitalization.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Initial Public Offering</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On May 3, 2021, the Company completed the initial public offering (“IPO”) of its common stock pursuant to a Registration Statement on Form S-1 (File No. 333-254981), which was declared effective by the SEC on April 28, 2021. The Company issued and sold an aggregate of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">42,236,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of common stock, including </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of common stock purchased by the underwriters on May 25, 2021 pursuant to the underwriters’ option to purchase additional shares at the initial public offering price, less underwriting discounts and commissions. The Company received net proceeds from the IPO of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">477.7</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million. On May 3, 2021, the Company used </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">307.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million of proceeds to repay in full all outstanding obligations under the second lien credit agreement dated as of March 16, 2017 (as amended, the “Prior Second Lien Credit Agreement”), thereby terminating the Prior Second Lien Credit Agreement. In addition, on May 4, 2021, the Company used </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">100.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million of proceeds to repay an equal amount of principal outstanding under its First Lien Credit Agreement (as defined in Note 7 – </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Long-term Obligations</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">). The remaining proceeds have been used for offering costs and general corporate purposes, including acquisitions.</span></p>
CY2022Q1	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	33
CY2021Q2	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	477700000
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Use of Estimates</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company’s accounting and reporting policies conform with U.S. GAAP. In preparing the consolidated financial statements, the Company is required to make estimates and assumptions that impact the amounts reported in these consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates.</span></p>
CY2022Q1	us-gaap	Restricted Cash RestrictedCash	0
CY2021Q1	us-gaap	Restricted Cash RestrictedCash	0
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	78353000
CY2021Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	63943000
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	46979000
CY2021Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	31293000
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	31374000
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	32650000
CY2022	us-gaap	Depreciation Depreciation	15300000
CY2021	us-gaap	Depreciation Depreciation	13000000.0
CY2019	us-gaap	Depreciation Depreciation	10100000
CY2022	avah	Current Leases Expiration Year CurrentLeasesExpirationYear	2030
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	117700000
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	75700000
CY2022	avah	Number Of Reporting Units Require Goodwill Impairment Testing NumberOfReportingUnitsRequireGoodwillImpairmentTesting	8
CY2021	avah	Number Of Reporting Units Require Goodwill Impairment Testing NumberOfReportingUnitsRequireGoodwillImpairmentTesting	8
CY2019	avah	Number Of Reporting Units Require Goodwill Impairment Testing NumberOfReportingUnitsRequireGoodwillImpairmentTesting	9
CY2021	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	1500000
CY2019	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	1100000
CY2022	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	8700000
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	7500000
CY2019	us-gaap	Interest Expense Debt InterestExpenseDebt	6700000
CY2022	us-gaap	Marketing Expense MarketingExpense	2900000
CY2021	us-gaap	Marketing Expense MarketingExpense	2700000
CY2019	us-gaap	Marketing Expense MarketingExpense	5700000
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Concentration of Credit Risk</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Financial instruments that potentially subject the Company to concentration of credit risk consist primarily of patient accounts receivable. Should government agencies suspend or significantly reduce contributions to government insurance programs, the Company’s ability to collect its receivables would be adversely affected. The Company’s exposure to credit risk with respect to its remaining receivables is limited due to the large number of state Medicaid, Medicaid Managed Care Organization payers, and Medicare Advantage payers.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company is also subject to credit risk due to the variable interest rates on its term loan obligations. As a result, the Company has entered into interest caps and interest rate swap agreements to limit its exposure to risk on its variable rate debt. See Note 10 – </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Derivative Financial Instruments</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> for further details on the interest rate derivative instruments.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company maintains its cash in bank deposit accounts with major financial institutions, which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts. The Company believes it is not exposed to significant credit risk on cash and cash equivalents.</span></p>
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3
CY2022	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3
CY2022Q1	avah	Estimated Price Concession EstimatedPriceConcession	55800000
CY2021Q1	avah	Estimated Price Concession EstimatedPriceConcession	55400000
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0
CY2019	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1678618000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1495105000
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1384065000
CY2022	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	12800000
CY2021Q2	avah	Reclassification Of Deferred Offering Cost Into Equity ReclassificationOfDeferredOfferingCostIntoEquity	7600000
CY2022	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	1902973000
CY2022	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-121082000
CY2021	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	1748915000
CY2021	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-98352000
CY2021	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	9600000
CY2018Q4	us-gaap	Goodwill Goodwill	1225420000
CY2019	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	549000
CY2019	us-gaap	Goodwill Translation And Purchase Accounting Adjustments GoodwillTranslationAndPurchaseAccountingAdjustments	95000
CY2019Q4	us-gaap	Goodwill Goodwill	1226064000
CY2021	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	166014000
CY2021	us-gaap	Goodwill Translation And Purchase Accounting Adjustments GoodwillTranslationAndPurchaseAccountingAdjustments	34000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4600000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3100000
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4200000
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	75727000
CY2021Q1	us-gaap	Goodwill Goodwill	1316385000
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	635230000
CY2022	us-gaap	Goodwill Translation And Purchase Accounting Adjustments GoodwillTranslationAndPurchaseAccountingAdjustments	1667000
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	117702000
CY2022Q1	us-gaap	Goodwill Goodwill	1835580000
CY2022Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	38803000
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	25555000
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	13248000
CY2022Q1	avah	Indefinite Lived Intangible Assets Gross Excluding Goodwill IndefiniteLivedIntangibleAssetsGrossExcludingGoodwill	93696000
CY2022Q1	avah	Indefinite Lived Intangible Assets Accumulated Impairment IndefiniteLivedIntangibleAssetsAccumulatedImpairment	4093000
CY2022Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	89603000
CY2022Q1	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	132499000
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	25555000
CY2022Q1	avah	Intangible Assets Accumulated Impairment IntangibleAssetsAccumulatedImpairment	4093000
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	102851000
CY2021Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	29300000
CY2021Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	20912000
CY2021Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	8388000
CY2021Q1	avah	Indefinite Lived Intangible Assets Gross Excluding Goodwill IndefiniteLivedIntangibleAssetsGrossExcludingGoodwill	69277000
CY2021Q1	avah	Indefinite Lived Intangible Assets Accumulated Impairment IndefiniteLivedIntangibleAssetsAccumulatedImpairment	4093000
CY2021Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	65184000
CY2021Q1	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	98577000
CY2021Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	20912000
CY2021Q1	avah	Intangible Assets Accumulated Impairment IntangibleAssetsAccumulatedImpairment	4093000
CY2021Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	73572000
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	6189000
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1642000
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1200000
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	781000
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	781000
CY2022Q1	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	9004000
CY2021Q1	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	9778000
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	2655000
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	13248000
CY2022Q1	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	24909000
CY2021Q1	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	27335000
CY2022Q1	us-gaap	Interest Payable Current InterestPayableCurrent	3671000
CY2021Q1	us-gaap	Interest Payable Current InterestPayableCurrent	2398000
CY2022Q1	us-gaap	Notes Payable Current NotesPayableCurrent	5111000
CY2021Q1	us-gaap	Notes Payable Current NotesPayableCurrent	2872000
CY2022Q1	avah	Tax Refund Due To Seller Current TaxRefundDueToSellerCurrent	7451000
CY2021Q1	avah	Tax Refund Due To Seller Current TaxRefundDueToSellerCurrent	8180000
CY2022Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	50146000
CY2021Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	50563000
CY2022Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1272850000
CY2021Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1204732000
CY2022Q1	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	37733000
CY2021Q1	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	31332000
CY2022Q1	us-gaap	Long Term Debt LongTermDebt	1235117000
CY2021Q1	us-gaap	Long Term Debt LongTermDebt	1173400000
CY2022Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	8600000
CY2021Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	9910000
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1226517000
CY2021Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1163490000
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	8600000
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	8600000
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	8600000
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	8600000
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	8600000
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	1229850000
CY2022Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1272850000
CY2021Q2	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	8900000
CY2021Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-400000
CY2021Q3	avah	Corporate Expenses CorporateExpenses	7000000.0
CY2021Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	8300000
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	8700000
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	7500000
CY2019	us-gaap	Interest Expense Debt InterestExpenseDebt	6700000
CY2022Q1	avah	Swingline Loan SwinglineLoan	0
CY2021Q1	avah	Swingline Loan SwinglineLoan	0
CY2022Q1	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	1272900000
CY2022Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	15342000
CY2021Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	28624000
CY2022Q1	us-gaap	Fair Value Liabilities Level1 To Level2 Transfers Amount FairValueLiabilitiesLevel1ToLevel2TransfersAmount	0
CY2021Q1	us-gaap	Fair Value Liabilities Level1 To Level2 Transfers Amount FairValueLiabilitiesLevel1ToLevel2TransfersAmount	0
CY2022Q1	us-gaap	Fair Value Liabilities Level2 To Level1 Transfers Amount FairValueLiabilitiesLevel2ToLevel1TransfersAmount	0
CY2021Q1	us-gaap	Fair Value Liabilities Level2 To Level1 Transfers Amount FairValueLiabilitiesLevel2ToLevel1TransfersAmount	0
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3	0
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3	0
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3	0
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3	0
CY2022Q1	us-gaap	Fair Value Assets Level1 To Level2 Transfers Amount FairValueAssetsLevel1ToLevel2TransfersAmount	0
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	2544000
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-3089000
CY2022Q1	us-gaap	Fair Value Assets Level2 To Level1 Transfers Amount FairValueAssetsLevel2ToLevel1TransfersAmount	0
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	0
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	0
CY2017Q4	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	581000
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	5461000
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	644000
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1574000
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	6280000
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1761000
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2155000
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	11741000
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2405000
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1231000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-3336000
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-241000
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-678000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1313000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-6425000
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-919000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3468000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5316000
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1486000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.034
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.036
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.010
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	0.170
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	0.269
CY2021	avah	Effective Income Tax Rate Reconciliation Non Taxable Escrow Settlement EffectiveIncomeTaxRateReconciliationNonTaxableEscrowSettlement	-0.203
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.016
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.046
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.016
CY2022	avah	Effective Income Tax Rate Reconciliation Uncertain Tax Positions EffectiveIncomeTaxRateReconciliationUncertainTaxPositions	-0.004
CY2021	avah	Effective Income Tax Rate Reconciliation Uncertain Tax Positions EffectiveIncomeTaxRateReconciliationUncertainTaxPositions	0.051
CY2019	avah	Effective Income Tax Rate Reconciliation Uncertain Tax Positions EffectiveIncomeTaxRateReconciliationUncertainTaxPositions	0.009
CY2019	avah	Effective Income Tax Rate Reconciliation Change In Deferred Balance Adjustment EffectiveIncomeTaxRateReconciliationChangeInDeferredBalanceAdjustment	0.020
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.031
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.134
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.176
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.006
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.020
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.001
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.031
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.103
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.020
CY2022Q1	avah	Deferred Tax Assets Contractual Adjustments And Discounts DeferredTaxAssetsContractualAdjustmentsAndDiscounts	14519000
CY2021Q1	avah	Deferred Tax Assets Contractual Adjustments And Discounts DeferredTaxAssetsContractualAdjustmentsAndDiscounts	14253000
CY2022Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	19628000
CY2021Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	7710000
CY2022Q1	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	2270000
CY2022Q1	avah	Deferred Tax Assets Payroll Related Accruals DeferredTaxAssetsPayrollRelatedAccruals	23562000
CY2021Q1	avah	Deferred Tax Assets Payroll Related Accruals DeferredTaxAssetsPayrollRelatedAccruals	28149000
CY2021Q1	avah	Deferred Tax Assets Grant Relief Funds DeferredTaxAssetsGrantReliefFunds	7901000
CY2022Q1	avah	Deferred Tax Assets Intangible Assets DeferredTaxAssetsIntangibleAssets	22270000
CY2021Q1	avah	Deferred Tax Assets Intangible Assets DeferredTaxAssetsIntangibleAssets	23618000
CY2022Q1	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	34931000
CY2021Q1	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	22074000
CY2022Q1	avah	Deferred Tax Assets Transaction Costs DeferredTaxAssetsTransactionCosts	4171000
CY2021Q1	avah	Deferred Tax Assets Transaction Costs DeferredTaxAssetsTransactionCosts	3001000
CY2022Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	4494000
CY2021Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	2738000
CY2022Q1	us-gaap	Deferred Tax Assets Derivative Instruments DeferredTaxAssetsDerivativeInstruments	4073000
CY2021Q1	us-gaap	Deferred Tax Assets Derivative Instruments DeferredTaxAssetsDerivativeInstruments	7419000
CY2022Q1	avah	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	15740000
CY2021Q1	avah	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	13908000
CY2022Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	5119000
CY2021Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	2011000
CY2022Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	254000
CY2021Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1066000
CY2022Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	151031000
CY2021Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	133848000
CY2022Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	105000000
CY2021Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	94041000
CY2021Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	700000
CY2022Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	46031000
CY2021Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	39807000
CY2022Q1	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	3281000
CY2021Q1	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	2226000
CY2022Q1	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill	26621000
CY2021Q1	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill	22657000
CY2022Q1	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	13751000
CY2021Q1	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	11880000
CY2022Q1	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	5424000
CY2021Q1	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	2704000
CY2022Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	49077000
CY2021Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	39467000
CY2022Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	3046000
CY2021Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	340000
CY2022	avah	Operating Loss Carryforwards Expiration Start Year OperatingLossCarryforwardsExpirationStartYear	2021
CY2022	avah	Operating Loss Carryforwards Expiration End Period OperatingLossCarryforwardsExpirationEndPeriod	2038
CY2022	avah	Maximum Percentage Of Taxpayers Adjusted Taxable Income Under Cares Act MaximumPercentageOfTaxpayersAdjustedTaxableIncomeUnderCaresAct	0.30
CY2021	avah	Maximum Percentage Of Taxpayers Adjusted Taxable Income Under Cares Act MaximumPercentageOfTaxpayersAdjustedTaxableIncomeUnderCaresAct	0.50
CY2019	avah	Maximum Percentage Of Taxpayers Adjusted Taxable Income Under Cares Act MaximumPercentageOfTaxpayersAdjustedTaxableIncomeUnderCaresAct	0.50
CY2022Q1	avah	Indefinite Lived Interest Expense Carryovers IndefiniteLivedInterestExpenseCarryovers	145800000
CY2022Q1	avah	Deferred Tax Asset Interest Carryforward Not Subject To Expiration DeferredTaxAssetInterestCarryforwardNotSubjectToExpiration	34900000
CY2022Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	105000000.0
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	11000000.0
CY2021Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	94000000.0
CY2021Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	94041000
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	79287000
CY2022	avah	Valuation Allowance Recorded Through Purchase Accounting ValuationAllowanceRecordedThroughPurchaseAccounting	1156000
CY2021	avah	Valuation Allowance Recorded Through Purchase Accounting ValuationAllowanceRecordedThroughPurchaseAccounting	1276000
CY2021	avah	Valuation Allowance Deferred Tax Asset Increase Decrease Due To Leases ValuationAllowanceDeferredTaxAssetIncreaseDecreaseDueToLeases	343000
CY2022	avah	Increase Decrease Deferred Tax Assets Valuation Allowances IncreaseDecreaseDeferredTaxAssetsValuationAllowances	9803000
CY2021	avah	Increase Decrease Deferred Tax Assets Valuation Allowances IncreaseDecreaseDeferredTaxAssetsValuationAllowances	13135000
CY2022Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	105000000
CY2021Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	94041000
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	10200000
CY2021Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	6200000
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3900000
CY2022Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	2000000.0
CY2019Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	100000
CY2022Q1	us-gaap	Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit	2100000
CY2022	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	1000000.0
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	18202000
CY2021Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	6182000
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3945000
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	308000
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	214000
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	794000
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	749000
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	4846000
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	1443000
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	2888000
CY2022	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	1002000
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	10240000
CY2021Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	6182000
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3945000
CY2021Q2	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	477700000
CY2022	us-gaap	Stockholders Equity Note Stock Split StockholdersEquityNoteStockSplit	effected a one-to-20.5 forward stock split
CY2021Q2	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	20.5
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000
CY2021Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2020Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	50000000.0
CY2022Q1	avah	Deferred Restricted Stock Units DeferredRestrictedStockUnits	2100000
CY2021Q1	avah	Deferred Restricted Stock Units DeferredRestrictedStockUnits	2100000
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	22927000
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	15422000
CY2019	us-gaap	Short Term Lease Cost ShortTermLeaseCost	374000
CY2022	avah	Current Leases Expiration Year CurrentLeasesExpirationYear	2030
CY2022	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	799000
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	51992000
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	46217000
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	13534000
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	11884000
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	44682000
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	40246000
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	58216000
CY2021Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	52130000
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	19326000
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	17919000
CY2019	us-gaap	Operating Lease Expense OperatingLeaseExpense	16846000
CY2019	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	402000
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	19326000
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	17919000
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	17248000
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	3206000
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	2795000
CY2019	us-gaap	Variable Lease Cost VariableLeaseCost	2518000
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	1919000
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	491000
CY2022	us-gaap	Lease Cost LeaseCost	24451000
CY2021	us-gaap	Lease Cost LeaseCost	21205000
CY2019	us-gaap	Lease Cost LeaseCost	20140000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	19697000
CY2021Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	1800000
CY2020Q1	us-gaap	Litigation Settlement Amount Awarded From Other Party LitigationSettlementAmountAwardedFromOtherParty	50000000.0
CY2018Q4	us-gaap	Provision For Loss On Contracts ProvisionForLossOnContracts	75000000.0
CY2021	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	366000
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y6M14D
CY2021Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y10M28D
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0829
CY2021Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0935
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	17884000
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	16466000
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	12676000
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	9336000
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	5953000
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	8676000
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	70992000
CY2022Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	12776000
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	58216000
CY2022	us-gaap	Lessee Finance Lease Description LesseeFinanceLeaseDescription	Financing leases include provisions to purchase the asset at the conclusion of the lease. The Company’s current leases have expiration dates through 2023. Financing assets of $0.9 million and $1.8 million are included in property and equipment, net on the consolidated balance sheets as of January 1, 2022 and January 2, 2021, respectively. Financing liabilities of $0.6 million and $0.7 million are included in other current liabilities and other long-term liabilities, respectively, on the consolidated balance sheets as of January 1, 2022 . Financing liabilities of $0.6 million and $1.5 million are included in other current liabilities and other long-term liabilities, respectively, on the consolidated balance sheets as of January 2, 2021.
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	900000
CY2022Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	600000
CY2022Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	700000
CY2021Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	600000
CY2021Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1500000
CY2021Q4	us-gaap	Malpractice Insurance Deductible1 MalpracticeInsuranceDeductible1	1000000.0
CY2021Q4	us-gaap	Malpractice Insurance Maximum Coverage Per Incident MalpracticeInsuranceMaximumCoveragePerIncident	5500000
CY2021Q3	us-gaap	Malpractice Insurance Deductible1 MalpracticeInsuranceDeductible1	500000
CY2021Q3	us-gaap	Malpractice Insurance Maximum Coverage Per Incident MalpracticeInsuranceMaximumCoveragePerIncident	6000000.0
CY2022Q1	us-gaap	Self Insurance Reserve SelfInsuranceReserve	80500000
CY2021Q1	us-gaap	Self Insurance Reserve SelfInsuranceReserve	74600000
CY2021	us-gaap	Gross Profit GrossProfit	454515000
CY2019Q4	avah	Break Up Fee Payable BreakUpFeePayable	0
CY2022	avah	Gross Margin Percentage GrossMarginPercentage	0.323
CY2022	us-gaap	Loss Contingency Name Of Defendant LossContingencyNameOfDefendant	Epic/Freedom, LLC (“Seller”), Webster Capital Corporation, and Webster Equity Partners (collectively, the “Defendants”)
CY2020Q3	us-gaap	Escrow Deposit EscrowDeposit	7100000
CY2022	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	4800000
CY2021	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	4200000
CY2019	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	3700000
CY2021	avah	Provider Relief Fund Payments Received Cares Act ProviderReliefFundPaymentsReceivedCARESAct	25100000
CY2021Q4	avah	Provider Relief Fund Payments Received Cares Act ProviderReliefFundPaymentsReceivedCARESAct	2500000
CY2022	avah	Incremental Percentage Of Deferred Payment Of Employer Portion Of Social Security Taxes IncrementalPercentageOfDeferredPaymentOfEmployerPortionOfSocialSecurityTaxes	0.50
CY2021Q4	avah	Percentage Of Social Security Tax Due Cares Act PercentageOfSocialSecurityTaxDueCARESAct	0.50
CY2021Q4	avah	Deferred Payroll Taxes Cares Act Paid DeferredPayrollTaxesCaresActPaid	25900000
CY2022Q1	avah	Deferred Social Security Tax Cares Act DeferredSocialSecurityTaxCARESAct	25500000
CY2021Q1	avah	Deferred Payroll Taxes Current Cares Act DeferredPayrollTaxesCurrentCaresAct	49600000
CY2022	us-gaap	Management Fee Expense ManagementFeeExpense	800000
CY2021	us-gaap	Management Fee Expense ManagementFeeExpense	3300000
CY2019	us-gaap	Management Fee Expense ManagementFeeExpense	3300000
CY2022Q1	avah	Advisory Services Expense Outstanding AdvisoryServicesExpenseOutstanding	0
CY2021Q1	avah	Advisory Services Expense Outstanding AdvisoryServicesExpenseOutstanding	1600000
CY2022	avah	Ownership Interest In Revenue Cycle Vendor Eligibility And Clearing House Billing Services OwnershipInterestInRevenueCycleVendorEligibilityAndClearingHouseBillingServices	400000
CY2021	avah	Ownership Interest In Revenue Cycle Vendor Eligibility And Clearing House Billing Services OwnershipInterestInRevenueCycleVendorEligibilityAndClearingHouseBillingServices	500000
CY2019	avah	Ownership Interest In Revenue Cycle Vendor Eligibility And Clearing House Billing Services OwnershipInterestInRevenueCycleVendorEligibilityAndClearingHouseBillingServices	400000
CY2022Q1	avah	Ownership Interest In Revenue Cycle Vendor Eligibility And Clearing House Billing Services Outstanding OwnershipInterestInRevenueCycleVendorEligibilityAndClearingHouseBillingServicesOutstanding	0
CY2021Q1	avah	Ownership Interest In Revenue Cycle Vendor Eligibility And Clearing House Billing Services Outstanding OwnershipInterestInRevenueCycleVendorEligibilityAndClearingHouseBillingServicesOutstanding	0
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3
CY2022	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1678618000
CY2022	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	1136214000
CY2022	us-gaap	Gross Profit GrossProfit	542404000
CY2021	avah	Gross Margin Percentage GrossMarginPercentage	0.304
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1384065000
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	253000
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	345000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1495105000
CY2021	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	1040590000
CY2019	us-gaap	Investment Income Interest InvestmentIncomeInterest	207000
CY2019	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	964814000
CY2019	us-gaap	Gross Profit GrossProfit	419251000
CY2019	avah	Gross Margin Percentage GrossMarginPercentage	0.303
CY2022	us-gaap	Gross Profit GrossProfit	542404000
CY2021	us-gaap	Gross Profit GrossProfit	454515000
CY2019	us-gaap	Gross Profit GrossProfit	419251000
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	297381000
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	240946000
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	227762000
CY2022	avah	Corporate Expenses CorporateExpenses	130387000
CY2021	avah	Corporate Expenses CorporateExpenses	113828000
CY2019	avah	Corporate Expenses CorporateExpenses	113235000
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	117702000
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	75727000
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	20550000
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	17027000
CY2019	us-gaap	Depreciation And Amortization DepreciationAndAmortization	14317000
CY2022	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	12832000
CY2021	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	9564000
CY2019	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	22661000
CY2022	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	337000
CY2021	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-910000
CY2019	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-2322000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-36111000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-3487000
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	38954000
CY2022	us-gaap	Interest Expense InterestExpense	68930000
CY2021	us-gaap	Interest Expense InterestExpense	82983000
CY2019	us-gaap	Interest Expense InterestExpense	92296000
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-13702000
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-73000
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-4858000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4914000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	34464000
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-17037000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-113576000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-51734000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-75030000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-117044000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-57050000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-76516000
CY2022	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	170625000
CY2021	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	140972000
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	136906000
CY2022	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.69
CY2021	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.40
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.56

Files In Submission

Name	View Source	Status
0000950170-22-004799-index-headers.html	Edgar Link	pending
0000950170-22-004799-index.html	Edgar Link	pending
0000950170-22-004799.txt	Edgar Link	pending
0000950170-22-004799-xbrl.zip	Edgar Link	pending
avah-20220101.htm	Edgar Link	pending
avah-20220101.xsd	Edgar Link	pending
avah-20220101_cal.xml	Edgar Link	unprocessable
avah-20220101_def.xml	Edgar Link	unprocessable
avah-20220101_htm.xml	Edgar Link	completed
avah-20220101_lab.xml	Edgar Link	unprocessable
avah-20220101_pre.xml	Edgar Link	unprocessable
avah-ex21_1.htm	Edgar Link	pending
avah-ex23_1.htm	Edgar Link	pending
avah-ex31_1.htm	Edgar Link	pending
avah-ex31_2.htm	Edgar Link	pending
avah-ex32_1.htm	Edgar Link	pending
avah-ex32_2.htm	Edgar Link	pending
avah-ex4_1.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
img22821201_0.jpg	Edgar Link	pending
img22821201_1.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AVAH
Aveanna Healthcare Holdings, Inc. Stock $avah

2022 Q1 Form 10-K Financial Statement

#000095017022004799 Filed on March 28, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AVAH Aveanna Healthcare Holdings, Inc. Stock $avah

2022 Q1 Form 10-K Financial Statement

#000095017022004799 Filed on March 28, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AVAH
Aveanna Healthcare Holdings, Inc. Stock $avah